)
Edge6 Mar 2026
Upvoted: The Story of Reddit
How Reddit built a unique platform around communities and conversation, turning human insight and intent into a distinctive business model.
Spermosens
Spermosens (SPERM) investor relations material
Spermosens Q4 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q4 2025 earnings summary11 Feb, 2026
Executive summary
Achieved key milestones in product development, clinical validation, and global patent approvals, focusing on transforming innovation into a market-ready diagnostic tool for male infertility.
Completed a pivotal clinical study in June, demonstrating a correlation between JUNO binding and fertilization rates, strengthening the product's clinical value.
Entered Memoranda of Understanding with Sapyen and RSI to advance commercialization and integration into clinical networks in the US and globally.
Financial highlights
Operating loss for 2025 was SEK -9,201 thousand, nearly flat compared to SEK -9,163 thousand in 2024.
Cash and cash equivalents at year-end increased to SEK 6,836 thousand from SEK 659 thousand the previous year.
Equity at period end rose to SEK 32,411 thousand from SEK 27,345 thousand year-over-year.
Total cash flow for the year was SEK 6,177 thousand, up from SEK -3,833 thousand in 2024.
Outlook and guidance
Generation 3 system development is on track, with completion and validation targeted for the first half of 2026.
Focus remains on technical and clinical validation to meet commercialization requirements and integration into fertility workflows.
Ongoing efforts to convert partnership frameworks into formal commercial agreements.
How JUNO binding data strengthens market position?
Next steps for MOUs to become commercial deals?
What are Gen 3 validation requirements?
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Spermosens
- Clinical validation, patent wins, and strong liquidity support next-gen product launch plans.SPERM
Q3 202512 Nov 2025 - Clinical validation and new funding support product development and market entry.SPERMQ2 202520 Aug 2025
- Clinical study progress, strategic partnerships, and capital raises drive Spermosens' 2024 outlook.SPERMQ3 202413 Jun 2025
- Operating loss narrows, but liquidity shortfall drives urgent capital raise and US expansion.SPERMQ2 202413 Jun 2025
- Positive clinical results and new funding position Spermosens for growth in fertility diagnostics.SPERMQ1 20256 Jun 2025
- Clinical progress and new partnerships drive outlook, but liquidity remains a key risk.SPERMQ4 20246 Jun 2025
Next Spermosens earnings date
Q1 20267 May, 2026
Spermosens
Next Spermosens earnings date
Q1 20267 May, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage